Palmatoplantar pustulosis
Conditions
Interventions
Control group:blank matrix
Sponsors
Ruijin Hospital Affiliated to Shanghai Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for palmoplantar pustulosis, with a history of more than 3 months; 2. Aged 18 to 65 years, gender is not limited; 3. Voluntarily sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who are known to be allergic to Ginnewer and other ingredients of this product, or have a history of allergy to external hormones or external retinoids; 2. Patients with bacterial and viral skin diseases (such as chickenpox, pyoderma, post-vaccination, herpes simplex, herpes zoster), fungal skin diseases, syphilitic skin lesions, skin tuberculosis within four weeks; 3. Diagnosed with sweaty eczematoid dermatitis, continuous acrodermatitis, pustular bacterial eruption; 4. Use at sites with significant inflammation, erosion or infection; 5. Skin lesions involving other parts of the body; 6. Have used other topical skin drugs (excluding moisturizers) within 2 weeks before enrollment; 7. Systemic application of hormones, acitretin, immunosuppressive agents, biological agents and phototherapy 1 month before enrollment; 8. Those who are pregnant, breastfeeding and those who plan to become pregnant; 9. Participate in other clinical investigators within the past 1 month; 10. There are mental disorders or the doctor thinks that it is not suitable to participate in the clinical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PPPASI 75; | — |
Secondary
| Measure | Time frame |
|---|---|
| PPPASI 90;PPPASI 50;PPPASI 25; | — |
Countries
China
Contacts
Public ContactLi Xia
Ruijin Hospital Affiliated to Shanghai Jiaotong University
Outcome results
None listed